Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: People with combined diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) often present with more severe metabolic derangements than those with DKA or HHS alone. This study aimed to clarify the clinical characteristics of HHS-DKA and explore predictive models for complications, including hypokalemia.

Methods:  We retrospectively analyzed data from 99 patients admitted with hyperglycemic emergencies between April 1, 2010, and October 31, 2024, and classified them into DKA, HHS, and HHS-DKA groups. A decision tree model was also developed to predict the risk of post-continuous insulin infusion (CII) hypokalemia. The decision tree model was created using machine learning with the Python language (Python Software Foundation, Wilmington, Delaware).

Results: HHS-DKA patients had significantly higher rates of acute kidney injury (84%) and hyperkalemia (58%) compared to those with DKA or HHS alone. A decision tree model predicted post-CII hypokalemia with 80% accuracy, identifying key predictors such as initial blood glucose and insulin flow rates.

Conclusion: HHS-DKA represents a distinct and severe clinical entity with unique characteristics and complications. Predictive models developed in this study will likely assist in risk stratification and improve patient management during hyperglycemic crises in emergency settings. However, as this was a single-center retrospective study without external validation, further studies are warranted to confirm these findings.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12182720PMC
http://dx.doi.org/10.7759/cureus.84672DOI Listing

Publication Analysis

Top Keywords

dka hhs
12
decision tree
12
tree model
12
clinical characteristics
8
hyperosmolar hyperglycemic
8
hyperglycemic state
8
diabetic ketoacidosis
8
single-center retrospective
8
predictive models
8
hhs-dka
5

Similar Publications

Introduction: Hyperglycemic crises, such as diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS), are life-threatening complications of diabetes. This study aimed to assess the impact of early initiation of non-insulin hypoglycemic agents on glycemic variation following acute management of DKA/HHS.

Research Design And Methods: This retrospective cohort study was conducted at King Abdulaziz Medical City and King Abdullah Specialized Children Hospital in Riyadh, Saudi Arabia.

View Article and Find Full Text PDF

Objective: To compare survival between cats diagnosed with a nonketotic hyperosmolar hyperglycemic state (HHS) and cats diagnosed with diabetic ketoacidosis (DKA), and to determine whether clinical parameters, clinicopathologic data, and insulin type are associated with survival. Secondary objectives were to evaluate whether these parameters were associated with survival in cats undergoing a generalized hyperglycemic diabetic crisis.

Design: Retrospective evaluation of medical records of cats diagnosed with DKA and HHS between 2000 and 2020.

View Article and Find Full Text PDF

Introduction: Diabetic ketoacidosis (DKA) is a serious complication in patients with diabetes. This study compares the outcomes of hospitalized DKA patients with and without cardiovascular disease (CVD). In addition, we assess outcomes between DKA and hyperosmolar hyperglycemic syndrome (HHS) in diabetes patients with CVD, and between those who developed DKA and those who did not.

View Article and Find Full Text PDF

Background: Acute hyperglycaemia is often accompanied by acid-base and electrolyte disorders as well as changes in serum osmolality which have a significant clinical impact. This study explores the prevalence of complex acid-base disorders in patients with hyperglycaemia, focusing on the limitations of current diagnostic criteria which primarily rely on pH, serum bicarbonate and anion gap.

Methods: A retrospective analysis of 1159 episodes of severe hyperglycaemia was performed.

View Article and Find Full Text PDF

Objective: Type 1 diabetes polygenic risk scores (PRS) offer a promising tool for identifying diabetes subtypes in adults with new-onset disease. We aimed to develop a pipeline for the clinical translation of type 1 diabetes PRS to support clinical decision-making within a large health system and to provide publicly available code for applying these methods to future PRS models.

Research Design And Methods: We adapted two established type 1 diabetes PRS models: a 67-SNP (GRS2) and a 7-SNP (AA7) score for a clinical genotyping platform and applied them to 73,346 participants in the biobank at the Colorado Center for Personalized Medicine (CCPM).

View Article and Find Full Text PDF